ELEVECTA™ Producer Cell Line For Inducible AAV Production

To deliver on the promise of AAV-based gene therapies beyond rare diseases, large quantities of robustly produced, high-quality AAV will be essential.

The ELEVECTA™ producer cell line, a stable platform for inducible AAV production, is a true producer cell line with Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the genome of the host cell. Only a single induction step is required to initiate AAV production.

Continue reading to learn more about this innovative gene therapy technology offering a simplified AAV manufacturing process, scalability, reproducibility, and reduced COGS.